AFP and neoplasm: The magnitude of tumor burden is heterogenous in this group, which is broken into three sub-classes: a group that falls within the extended liver transplant criteria based on size/AFP; a group characterized by a well-defined tumor burden with preserved portal flow and targets for liver-directed therapy; and a class with diffuse infiltration that precludes effective locoregional therapy, thus making systemic therapy the only potential treatment option.